Eya4-deficient mice are a model for heritable otitis media

Journal of Clinical Investigation

Volumn 118, Issue 2, 2008, Pages 651-658

  Depreux, Frederic F S ^a   Darrow, Keith ^b   Conner, David A ^a   Eavey, Roland D ^a,b   Liberman, M Charles ^b   Seidman, Christine E ^a,c   Seidman, J G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY TUBE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FUNCTION; GENETIC SUSCEPTIBILITY; HEARING IMPAIRMENT; MALE; MIDDLE EAR; MIDDLE EAR EFFUSION; MOUSE; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; TERATOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; EAR, MIDDLE; EUSTACHIAN TUBE; GENETIC PREDISPOSITION TO DISEASE; HEARING LOSS, SENSORINEURAL; MICE; MICE, MUTANT STRAINS; MUTATION; OTITIS MEDIA WITH EFFUSION; TRANS-ACTIVATORS;

EID: 38849181806     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32899     Document Type: Article

References (48)

1. Schappert, S.M. 1992. Office visits for otitis media: United States, 1975-90. Adv. Data. 214:1-19.
2. Bondy, J., Berman, S., Glazner, J., and Lezotte, D. 2000. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort. Pediatrics. 105:E72.
3. Paradise, J.L., et al. 1997. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 99:318-333.
4. Paradise, J.L., et al. 2003. Otitis media and tympanostomy tube insertion during the first three years of life: developmental outcomes at the age of four years. Pediatrics. 112:265-277.
5. Bluestone, C.D. 2005. The Eustachian tube: structure, function and role in the middle ear. B.C. Decker, Inc. Hamilton, Ontario, Canada. 240 pp.
6. Casselbrant, M.L., et al. 1999. The heritability of otitis media: a twin and triplet study. JAMA. 282:2125-2130.
7. Casselbrant, M.L., and Mandel, E.M. 2005. Genetic susceptibility to otitis media. Curr. Opin. Allergy Clin. Immunol. 5:1-4.
8. Online Mendelian Inheritance in Man. http://www.ncbi.nlm.nih.gov/sites/ entrez?db=OMIM.
9. Chen, A., et al. 1995. Phenotypic manifestations of branchio-oto-renal syndrome. Am. J. Med. Genet. 58:365-370.
10. Pfister, M., et al. 2002. A 4-bp insertion in the eyahomologous region (eyaHR) of EYA4 causes hearing impairment in a Hungarian family linked to DFNA10. Mol. Med. 8:607-611.
11. Wayne, S., et al. 2001. Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum. Mol. Genet. 10:195-200.
12. O'Neill, M.E., et al. 1996. A gene for autosomal dominant late-onset progressive non-syndromic hearing loss, DFNA10, maps to chromosome 6. Hum. Mol. Genet. 5:853-856.
13. Schonberger, J., et al. 2005. Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat. Genet. 37:418-422.
14. De Leenheer, E.M., et al. 2002. DFNA10/EYA4 - the clinical picture. Adv. Otorhinolaryngol. 61:73-78.
15. Ohto, H., et al. 1999. Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol. Cell. Biol. 19:6815-6824.
16. Borsani, G., et al. 1999. EYA4, a novel vertebrate gene related to Drosophila eyes absent. Hum. Mol. Genet. 8:11-23.
17. Rayapureddi, J.P., et al. 2003. Eyes absent represents a class of protein tyrosine phosphatases. Nature. 426:295-298.
18. Tootle, T.L., et al. 2003. The transcription factor Eyes absent is a protein tyrosine phosphatase. Nature. 426:299-302.
19. Li, X., et al. 2003. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature. 426:247-254.
20. Rebay, I., Silver, S.J., and Tootle, T.L. 2005. New vision from Eyes absent: transcription factors as enzymes. Trends Genet. 21:163-171.
21. Rosowski, J.J., Brinsko, K.M., Tempel, B.I., and Kujawa, S.G. 2003. The aging of the middle ear in 129S6/SvEvTac and CBA/CaJ mice: measurements of umbo velocity, hearing function, and the incidence of pathology. J. Assoc. Res. Otolaryngol. 4:371-383.
22. McGinn, M.D., Bean-Knudsen, D., and Ermel, R.W. 1992. Incidence of otitis media in CBA/J and CBA/CaJ mice. Hear. Res. 59:1-6.
23. Park, K., and Lim, D.J. 1992. Luminal development of the eustachian tube and middle ear: murine model. Yonsei Med. J. 33:159-167.
24. Roberts, D.S., and Miller, S.A. 1998. Apoptosis in cavitation of middle ear space. Anat. Rec. 251:286-289.
25. Girard, D., Finegan, S.M., Dunne, M.W., and Lame, M.E. 2005. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models. J. Antimicrob. Chemother. 56:365-371.
26. Kubba, H., Pearson, J.P., and Birchall, J.P. 2000. The aetiology of otitis media with effusion: a review. Clin. Otolaryngol. Allied Sci. 25:181-194.
27. Xu, P.X., et al. 1999. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat. Genet. 23:113-117.
28. Mallo, M. 2003. Formation of the outer and middle ear, molecular mechanisms. Curr Top Dev. Biol. 57:85-113.
29. el-Sayed, Y., al-Sarhani, A., and al-Essa, A.R. 1997. Otological manifestations of primary ciliary dyskinesia. Clin. Otolaryngol. Allied Sci. 22:266-270.
30. Zheng, W., et al. 2003. The role of Six1 in mammalian auditory system development. Development. 130:3989-4000.
31. Hardisty, R.E., et al. 2003. The deaf mouse mutant Jeff (Jf) is a single gene model of otitis media. J. Assoc. Res. Otolaryngol. 4:130-138.
32. Hardisty-Hughes, R.E., et al. 2006. A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse. Hum. Mol. Genet. 15:3273-3279.
33. Piza, J., Northrop, C., and Eavey, R.D. 1998. Embryonic middle ear mesenchyme disappears by redistribution. Laryngoscope. 108:1378-1381.
34. Larsen, P.L., Tos, M., Kuijpers, W., and van der Beek, J.M. 1992. The early stages of polyp formation. Laryngoscope. 102:670-677.
35. Matsune, S., Sando, I., and Takahashi, H. 1992. Distributions of eustachian tube goblet cells and glands in children with and without otitis media. Ann. Otol. Rhinol. Laryngol. 101:750-754.
36. Steel, K.P., Moorjani, P., and Bock, G.R. 1987. Mixed conductive and sensorineural hearing loss in LP/J mice. Hear. Res. 28:227-236.
37. Vogler, C., et al. 2001. A novel model of murine mucopolysaccharidosis type VII due to an intracisternal a particle element transposition into the beta-glucuronidase gene: clinical and pathologic findings. Pediatr. Res. 49:342-348.
38. Liao, J., et al. 2004. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum. Mol. Genet. 13:1577-1585.
39. Schmidt-Ullrich, R., et al. 2001. Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. Development. 128:3843-3853.
40. Yang, A., et al. 2000. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature. 404:99-103.
41. MacArthur, C.J., Hefeneider, S.H., Kempton, J.B., and Trune, D.R. 2006. C3H/HeJ mouse model for spontaneous chronic otitis media. Laryngoscope. 116:1071-1079.
42. Parkinson, N., et al. 2006. Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media. PLoS Genet. 2:e149.
43. Zhang, Y., Buchholz, F., Muyrers, J.P., and Stewart, A.F. 1998. A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet. 20:123-128.
44. Pizard, A., et al. 2005. Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum. Mol. Cell. Biol. 25:5073-5083.
45. Darrow, K.N., Maison, S.F., and Liberman, M.C. 2007. Selective removal of lateral olivocochlear efferents increases vulnerability to acute acoustic injury. J. Neurophysiol. 97:1775-1785.
46. Maison, S.F., et al. 2003. Loss of alpha CGRP reduces sound-evoked activity in the cochlear nerve. J. Neurophysiol. 90:2941-2949.
47. Girard, A.E., et al. 1987. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob. Agents. Chemother. 31:1948-1954.
48. Hirose, K., and Liberman, M.C. 2003. Lateral wall histopathology and endocochlear potential in the noise-damaged mouse cochlea. J. Assoc. Res. Otolaryngol. 4:339-352.